Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
UCB-0022 by UCB for Parkinson's Disease: Likelihood of Approval
UCB-0022 is under clinical development by UCB and currently in Phase II for Parkinson's Disease. According to GlobalData, Phase II...